DexCom, Inc. (DXCM) — Stock Valuation & Research

DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional…

DXCM key statistics

Price$89.56
Market cap$33.8B
SectorHealthcare
IndustryMedical - Devices
ExchangeNASDAQ
52-week range54.11-92.59
Beta1.42

Explore DXCM's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.